Novel Potential Biomarker in ANCA-Associated Vasculitis Reported
Pentraxin-3 appears to reflect disease activity better than C-reactive protein.
Pentraxin-3 appears to reflect disease activity better than C-reactive protein.
Kidney function remained stable throughout the 25 week treatment period.
Slow metabolizers of caffeine genetically comprise half of the Italian population.
Japanese guidelines recommend the use of urate-lowering drugs for the treatment of asymptomatic hyperuricemia.
Sparsentan is a dual endothelin and angiotensin receptor antagonist.
Study findings indicate synergistic effects of SGLT2 inhibitors and MRAs on albuminuria.
Study findings suggest targeted inhibition of APOL1 function can reduce proteinuria.
ASPREE trial data offered a “unique opportunity” to assess bleeding risk in older populations with and without CKD.
The ratio is a clinically meaningful indicator that is easily obtained from blood test results, according to investigators.
The National Kidney Foundation recently hosted a scientific workshop to improve the clinical care of children with CKD.